In the last couple of years, liquid biopsy has gained the attention of many. This may not come as a surprise considering the ability of detecting and characterizing tumors in such a modestly and repeatable manner could bring about clinical implications. No wonder tremendous devices have been developed to do just that.
Despite this, the technique is yet to become a standard tool relied upon at all times by clinical oncologists. With so many things to focus on, the research community seems to be losing focus considering there is a wide range of assays based on different principles.
Worse, Circulating Tumor Cells (CTCs) and Circulating cell-free tumor DNA (ctDNA), the two biomarkers detected by liquid biopsy are still subject to technical variability. This is mostly the case when it comes to pre-analytical and analytical steps.
Fortunately, efforts are already underway to address these issues thus making sure liquid biopsy is in the hands of more clinicians all around the world. However, this does not mean their main intention is selecting and refining a single approach to liquid biopsy.
Rather, the main focus is figuring out the specific combination that signal the status of a given health complication be it lung cancer or any other type, origin and progression. Things do not end there since we also have to keep a close eye on the immune cells of the circulating microenvironment.
Since researchers have known about the capabilities of liquid biopsies for some time now, more interventional clinical trials are mandatory to make it a success. But how can this be achieved without compromising on anything?
Well, that is where policymakers in the industry need to step in. In so doing, it will prove quite easy to employ elegant and powerful techniques thus making it a rapid, reliable and non-invasive decision-making tool we can count on at all times.
Rounding Up
The future of liquid biopsy lung cancer seems to be bright as more innovations continue to be made. What is even more fascinating is the fact that the awareness of liquid biopsy is high among clinicians in different parts of the world.
To avoid being left behind, you ought to know what is taking place. Fortunately, this is something you no longer have to worry about when you have a clear insight into what lung cancer entails and how to perfectly diagnose and treat it.
